Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis.

BACKGROUND Although calcium channel blockers (CCB) are highly effective for suppression of vasospastic angina (VSA) attacks, their prognostic effects in VSA patients remain to be examined in a large number of patients. METHODS AND RESULTS Databases for related papers were searched and then a meta-analysis regarding the effects of CCB on major adverse cardiovascular events (MACE) in Japanese VSA patients with the 4 previous studies was performed. A total of 1,997 patients with positive coronary spasm provocation tests were evaluated. They were treated with either alone or combination of benidipine (n=320), amlodipine (n=308), nifedipine (n=182) or diltiazem (n=960). MACE were observed in 143 patients (cardiac death: 36, myocardial infarction: 51, heart failure: 26, stroke: 65, and aortic aneurysm: 11). The hazard ratio for the occurrence of MACE was significantly lower in patients treated with benidipine than in those with diltiazem. There was no significant difference in the clinical characteristics affecting the occurrence of MACE among the 4 CCB groups. Furthermore, the hazard ratio for the occurrence of MACE was significantly lower in those treated with benidipine, even after correction for patient characteristics that could have affected the occurrence of MACE (hazard ratio 0.41, P=0.016). CONCLUSIONS These results suggest that among the 4 major CCB that effectively suppress VSA attacks in general, benidipine showed significantly more beneficial prognostic effects than others.

[1]  H. Daida,et al.  Clinical Efficacy of Benidipine for Vasospastic Angina pectoris , 2007, Arzneimittelforschung.

[2]  A. Maseri,et al.  Role of coronary vasoconstriction in ischemic heart disease and search for novel therapeutic targets. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[3]  A. Maseri,et al.  Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. , 1999, Journal of the American College of Cardiology.

[4]  H. Yasue,et al.  Efficacy of slow-release nifedipine on ischemic attacks in patients with variant angina , 1990, Cardiovascular Drugs and Therapy.

[5]  R. Mongiardo,et al.  Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. , 2000, Circulation.

[6]  M. Arai,et al.  Benidipine Reduces Myocardial Infarct Size Involving Reduction of Hydroxyl Radicals and Production of Protein Kinase C-Dependent Nitric Oxide in Rabbits , 2004, Journal of cardiovascular pharmacology.

[7]  K. Kubo,et al.  Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries. , 1988, Japanese journal of pharmacology.

[8]  K. Kitamura,et al.  Long-Term Anti-Hypertensive Therapy with Benidipine Improves Arterial Stiffness over Blood Pressure Lowering , 2005, Hypertension Research.

[9]  M. Shimizu,et al.  Differential effects of calcium-channel blockers on vascular endothelial function in patients with coronary spastic angina. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[10]  M. Nakamura,et al.  Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. , 1988, International journal of cardiology.

[11]  M. Yamagishi,et al.  Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[12]  K. Nishigaki,et al.  Effects of Benidipine and Some Other Calcium Channel Blockers on the Prognosis of Patients with Vasospastic Angina , 2007, Arzneimittelforschung.

[13]  H. Kishida,et al.  Treatment of Variant Angina with Drugs: A Survey of 11 Cardiology Institutes in Japan , 1981, Circulation.

[14]  H. Yasue,et al.  Coronary Arterial Spasm in Ischemic Heart Disease and Its Pathogenesis: A Review , 1983, Circulation research.

[15]  M. Horie,et al.  Long-term prognosis for patients with variant angina and influential factors. , 1988, Circulation.

[16]  K. Kubo,et al.  Pharmacological actions of benidipine hydrochloride in several isolated smooth muscles and myocardium. , 1988, Arzneimittel-Forschung.

[17]  H. Shimokawa,et al.  Changing Characteristics of Patients with Vasospastic Angina in the Era of New Calcium Channel Blockers , 2004, Journal of cardiovascular pharmacology.

[18]  T. Akasaka,et al.  Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[19]  H. Takane,et al.  Long-term effects of calcium antagonists on augmentation index in hypertensive patients with chronic kidney diseases , 2009, NDT plus.

[20]  T Iga,et al.  Comparative pharmacodynamics of eight calcium channel blocking agents in Japanese essential hypertensive patients. , 1996, Biological & pharmaceutical bulletin.

[21]  H. Shimokawa,et al.  Prognostic Effects of Benidipine in Patients With Vasospastic Angina: Comparison With Diltiazem and Amlodipine , 2008, Journal of cardiovascular pharmacology.

[22]  Y. Nakamura,et al.  Effects of pacing-induced ischemia on early left ventricular filling and regional myocardial dynamics and their modification by nifedipine. , 1987, Circulation.

[23]  H. Yasue,et al.  Efficacy of slow-release nifedipine on myocardial ischemic episodes in variant angina pectoris. , 1991, The American journal of cardiology.

[24]  M. Aoki,et al.  A calcium‐channel blocker, benidipine, improves forearm reactive hyperemia in patients with essential hypertension , 2005, Blood pressure. Supplement.

[25]  KazuyaShinozaki,et al.  Insulin Resistance Associated With Compensatory Hyperinsulinemia as an Independent Risk Factor for Vasospastic Angina , 1995 .

[26]  A. Karasawa,et al.  Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs. , 1994, Biological & pharmaceutical bulletin.